中东和非洲生物生产市场预测至 2030 年 - 区域分析 - 按产品(生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸疗法等)、应用(类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等)、设备(上游设备、下游设备、生物反应器、消耗品和配件)和最终用户(生物制药公司、合同制造组织等)

BMIRE00030061 | Pages: 100 | Biotechnology | May 2024 | Type: Regional | Status: Published
2022 年,中东和非洲生物生产市场价值为 2.8368 亿美元,预计到 2030 年将达到 6.5296 亿美元;预计 2022 年至 2030 年的复合年增长率为 11.0%。

向自动化细胞疗法制造的转变促进了中东和非洲生物生产市场的发展

自动化可以为细胞疗法开发商带来许多好处,包括降低污染风险、提高一致性和降低生产成本。许多公司都提供了实现自动化的设备,例如 Lonza Cocoon 和 Miltenyi 的 CliniMACS Prodigy 系统旨在实现单个系统内 CAR-T 工艺中大多数连续单元操作的自动化。越来越多的细胞疗法已将全球细胞疗法产品的生产从小批量转移到大批量。此外,细胞疗法从学术和临床环境向大规模生产和商业化的发展,也增加了对制造业自动化的需求。细胞疗法研究活动的增加导致对先进制造解决方案的需求增加。鉴于此,许多参与者正在提供产品以满足学术研究人员和大型生物技术公司的数字需求。例如,2019 年 5 月,GE Healthcare 推出了 Chronicle Web 应用程序来支持完整的细胞治疗工作流程。Chronicle 自动化软件是一种符合良好生产规范 (GMP) 的数字解决方案,旨在优化复杂的细胞治疗工艺开发和制造。

公司也在进行细胞治疗自动化的战略和技术开发。例如,2020 年 7 月,Thermo Fisher Scientific Inc. 和 Lyell Immunopharma 合作开发和制造流程,为癌症患者设计有效的细胞疗法。根据这一合作关系,两家公司旨在提高 T 细胞的适应性,并支持开发符合现行良好生产规范 (cGMP) 的综合平台(系统和软件)以及试剂、耗材和仪器。因此,预计细胞治疗制造商越来越多地采用自动化将推动市场发展。

中东和非洲生物生产市场概览

中东和非洲的生物生产市场包括对阿联酋、沙特阿拉伯、南非和中东及非洲其他地区的国家级分析。生物生产市场的增长可以归因于政府政策的变化、公私伙伴关系的增加以及医疗保健基础设施的改善。此外,对先进和有效细胞疗法的需求不断增长,促进了市场的增长。

根据国际药物经济学和成果研究学会 (ISPOR) 的数据,心血管疾病是 2020 年沙特阿拉伯的首要死亡原因,占所有死亡病例的 45.7%。此外,由于不健康的饮食习惯和久坐的生活方式,沙特阿拉伯的糖尿病患病率很高。根据 IDF 的数据,2021 年沙特阿拉伯的糖尿病发病率为 8% 至 22%。导致糖尿病的主要因素是肥胖、不健康的生活方式和遗传易感性。根据一项全国性调查,2022 年沙特阿拉伯的心血管疾病患病率为 5.5%。因此,沙特阿拉伯心血管疾病和糖尿病发病率的上升正在推动生物生产市场的增长。

中东和非洲生物生产市场收入及预测至 2030 年(百万美元)

中东和非洲生物生产市场细分

中东和非洲生物生产市场分为产品、应用、设备、最终用户和国家。

基于产品,中东和非洲生物生产市场细分为生物制剂和生物仿制药、疫苗、细胞和基因疗法、核酸治疗等。生物制剂和生物仿制药部门在 2022 年占据了中东和非洲生物生产市场的最大份额。

在应用方面,中东和非洲生物生产市场细分为类风湿性关节炎、血液病、癌症、糖尿病、心血管疾病等。 2022 年,癌症部门占据了中东和非洲生物生产市场的最大份额。

按设备划分,中东和非洲生物生产市场分为上游设备、下游设备、生物反应器以及耗材和配件。2022 年,耗材和配件部门占据了中东和非洲生物生产市场的最大份额。

就最终用户而言,中东和非洲生物生产市场分为生物制药公司、合同制造组织和其他。2022 年,生物制药公司部门占据了中东和非洲生物生产市场的最大份额。

按国家划分,中东和非洲生物生产市场分为沙特阿拉伯、阿联酋、南非和中东及非洲其他地区。 2022 年,沙特阿拉伯占据了中东和非洲生物生产市场的主导份额。

Lonza Group AG、Danaher Corp、Sartorius AG、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd 和 Bio-Rad Laboratories Inc. 是中东和非洲生物生产市场的一些领先公司。

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Adoption of Regenerative Medicines

4.1.2 Increasing Prevalence of Chronic Diseases

4.2 Market Restraints

4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing

4.3 Market Opportunities

4.3.1 Patent Expiry of Blockbuster Biologics

4.4 Future Trends

4.4.1 Shift Toward Automated Cell Therapy Manufacturing

4.5 Impact Analysis

5. Bioproduction Market - Middle East & Africa Market Analysis

5.1 Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Biologics and Biosimilars

6.3.1 Overview

6.3.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Vaccines

6.4.1 Overview

6.4.2 Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Cell and Gene Therapies

6.5.1 Overview

6.5.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Nucleic Acid Therapeutics

6.6.1 Overview

6.6.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Cancer

7.3.1 Overview

7.3.2 Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Rheumatoid Arthritis

7.5.1 Overview

7.5.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Hematological Disorders

7.6.1 Overview

7.6.2 Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Diabetes

7.7.1 Overview

7.7.2 Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview

8.2 Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

8.3 Consumables and Accessories

8.3.1 Overview

8.3.2 Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Downstream Equipment

8.4.1 Overview

8.4.2 Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Bioreactors

8.5.1 Overview

8.5.2 Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5.2.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

8.6 Upstream Equipment

8.6.1 Overview

8.6.2 Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview

9.2 Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

9.3 Biopharmaceutical Companies

9.3.1 Overview

9.3.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Contract Manufacturing Organizations

9.4.1 Overview

9.4.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Middle East & Africa Bioproduction Market

10.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.2 Saudi Arabia: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.1.3 Saudi Arabia: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.1.4 Saudi Arabia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.1.4.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.1.5 Saudi Arabia: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 South Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.2.4 South Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.2.5 South Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.2.6 South Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.3 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 UAE: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.3.4 UAE: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.3.5 UAE: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.3.6 UAE: Bioproduction Market, by End User, 2020-2030 (US$ Million)

10.1.1.4 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)

10.1.1.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)

10.1.1.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Bioproduction Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1. Lonza Group AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Danaher Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Sartorius AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Thermo Fisher Scientific Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Merck KGaA

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 F. Hoffmann-La Roche Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Bio-Rad Laboratories Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Middle East & Africa Bioproduction Market Segmentation

Table 2. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 3. Saudi Arabia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 4. Saudi Arabia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 5. Saudi Arabia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 6. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Saudi Arabia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. South Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. South Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. South Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 11. South Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 12. South Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 13. UAE Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 14. UAE Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 15. UAE Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 16. UAE Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 17. UAE Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Middle East & Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Middle East & Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 20. Rest of Middle East & Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 21. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)

Table 22. Rest of Middle East & Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 23. Recent Inorganic Growth Strategies in the Bioproduction Market

Table 24. Recent Organic Growth Strategies in the Bioproduction Market

Table 25. Glossary of Terms, Bioproduction Market

?

List of Figures

Figure 1. Middle East & Africa Bioproduction Market Segmentation, By Country

Figure 2. Middle East & Africa Bioproduction Market: Key Industry Dynamics

Figure 3. Middle East & Africa Bioproduction Market: Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

Figure 19. Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

Figure 24. Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Middle East & Africa: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)

Figure 28. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)

Figure 29. Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 30. South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 33. Growth Strategies in the Bioproduction Market

1. Lonza Group AG

 

2. Danaher Corp

3. Sartorius AG

4. Thermo Fisher Scientific Inc

5. Merck KGaA

6. F. Hoffmann-La Roche Ltd

7. Bio-Rad Laboratories Inc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioproduction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioproduction market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440